Bone morphogenetic protein receptor 2 mutations in pulmonary hypertension.

Bone morphogenetic protein receptor 2 mutations in pulmonary hypertension. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Bone morphogenetic protein receptor 2 mutations in pulmonary hypertension. Abstract Text:

Jane H Morse,

Bone morphogenetic protein receptor 2 mutations in pulmonary hypertension. Publishing Authors By Initials

JH Morse,

For similar peptides: intercellular signaling peptides and proteins: cytokines: transforming growth factor beta research abstracts see: peptides: intercellular signaling peptides and proteins: cytokines: transforming growth factor beta research

PUBMED ID PMID:

MEDLINE DATE:

Bone morphogenetic protein receptor 2 mutations in pulmonary hypertension. Journal Published:

PUBLICATION TYPE: Research Support, U.S. Gov't,

Journal: Chest

VOLUME: 121

Page Numbers: 50S-53S

Journal Abbreviation: Chest

ISSN: 0012-3692

DAY: 19

MONTH: Mar

YEAR: 2002

Bone morphogenetic protein receptor 2 mutations in pulmonary hypertension. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 231335

Bone morphogenetic protein receptor 2 mutations in pulmonary hypertension. Keywords Mesh Terms:

KEYWORDS: Transforming Growth Factor beta

MESH TERMS: metabolism

Chemical & Substance for Abstract: Bone morphogenetic protein receptor 2 mutations in pulmonary hypertension. Information

Substance Name: Protein-Serine-Threonine Kinases

Registry Number: EC 2.7.11.1

Grant and Affiliation Information for Bone morphogenetic protein receptor 2 mutations in pulmonary hypertension.

AFFILIATION: Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA.

Country: United States

AGENCY: United States NHLBI

GRANT: HL-60056

ACRONYM: HL

MEDLINETA: Chest

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Bone morphogenetic protein receptor 2 mutations in pulmonary hypertension Related Publications

• A dinoflagellate AAA family member rescues a conditional yeast G1/S phase cyclin mutant through increased CLB5 accumulation.
• Advances in pharmacogenomics of antiretrovirals: an update.
• Anaplastic, plasmablastic, and plasmacytic plasmacytomas of mice: relationships to human plasma cell neoplasms and late-stage differentiation of normal B cells.
• Assessing the impact of substance use and hepatitis coinfection on atazanavir and lopinavir trough concentrations in HIV-infected patients during therapeutic drug monitoring.
• Bone morphogenetic protein receptor 2 mutations in pulmonary hypertension.
• Buprenorphine assay and plasma concentration monitoring in HIV-infected substance users.
• Compartmental pharmacokinetic analysis of oral amprenavir with secondary peaks.
• Determination of lopinavir cerebral spinal fluid and plasma ultrafiltrate concentrations by liquid chromatography coupled to tandem mass spectrometry.
• Direct selection of RNA beacon aptamers.
• Drug interactions between proton pump inhibitors and antiretroviral drugs.
• Duplicate publication.
• Effects of pyriproxyfen on California red scale (Hemiptera: Diaspididae) development and reproduction.
• Functional deficiency in IL-7 caused by an N-ethyl-N-nitrosourea-induced point mutation.
• Genome-wide analysis of transcriptional dependence and probable target sites for Abf1 and Rap1 in Saccharomyces cerevisiae.
• Global infectious disease surveillance and health intelligence.
• Global preparedness for public health emergencies.
• HIV pharmacotherapy issues, challenges, and priorities in sub-Saharan African countries.
• Hierarchical assembly of the siliceous skeletal lattice of the hexactinellid sponge Euplectella aspergillum.
• High resolution Fourier-domain optical coherence tomography of retinal angiomatous proliferation.
• Integration of atazanavir into an existing liquid chromatography UV method for protease inhibitors: validation and application.
• Multidrug resistance 1 polymorphisms and trough concentrations of atazanavir and lopinavir in patients with HIV.
• Pandemic influenza: studying the lessons of history.
• Rotationally resolved spectroscopy of jet-cooled NbMo.
• Simulations of dynamics and viscoelasticity in highly entangled solutions of semiflexible rods.
• Technology evaluation: BLP-25, Biomira Inc.
• The US pandemic influenza implementation plan at six months.
• Toxicity of systemic neonicotinoid insecticides to avocado thrips in nursery avocado trees.
• Transcription factor access to promoter elements.
• Use of the finite element method to assess impact of current on forearm and wrist during an electrical accident.
• Wide dynamic range germanium detector for perturbation crystallography.